Richard Ogborne, PhD

Strategic life sciences leader with over 25 years of experience spanning R&D, global pharma and life science strategy consulting. Known for helping biotech and pharmaceutical companies make critical decisions about how to develop, prioritise and commercialise their assets. Brings a rare combination of scientific training, industry leadership and strategic advisory experience, enabling organisations to bridge the gap between scientific innovation and commercial success.
Experienced in supporting leadership teams, investors and boards on high-stakes decisions including asset development strategy, portfolio prioritisation, commercial readiness and investment evaluation.
Previously held leadership roles at AstraZeneca and senior consulting leadership positions advising biotech companies, pharmaceutical organisations and investors on strategic development and commercialisation decisions. Combines strong analytical judgement with an ability to influence leadership.